Supporting sustainable and equitable access to essential antibiotics
What is SECURE?
Established by the World Health Organization (WHO) and the Global Antibiotic Research & Development Partnership (GARDP), SECURE works directly with countries to understand their public health needs and challenges with access to antibiotics. By collaborating with existing procurement mechanisms and key partners, SECURE supports sustainable, equitable access to life-saving treatments—especially in low- and middle-income countries.
For more information on SECURE, click here.
Our Role
Woodseer has formally concluded its advisory engagement supporting the Global Antibiotic Research and Development Partnership (GARDP) on the SECURE Initiative. Over the course of the project, Woodseer led strategic partner engagement and access pathway planning across Southeast Asia, establishing durable institutional relationships and foundational frameworks for regional programme advancement. As with all Woodseer advisory mandates, delivery focused on grounded execution, stakeholder alignment, and practical regional readiness to support long-term public health impact. With these operational foundations firmly in place, the mandate reaches its natural conclusion, and we extend our sincere appreciation to the GARDP team for a productive and collegial partnership.
Driving Impact in Malaysia and Thailand
We are committed to the successful roll-out of SECURE in Malaysia and Thailand. By leveraging the trust we've built with stakeholders across the health ecosystem, we are facilitating the introduction of SECURE's innovative model in these two countries—laying the groundwork for wider adoption across the ASEAN region.
Promoting Sustainable Access
Our goal is to contribute to long-term, region-wide improvements in access to antibiotics. Through SECURE, we support efforts to promote responsible antibiotic use and strengthen supply systems, ensuring that essential medicines remain available, effective, and accessible for those who need them most.